Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
Dilek Gogas YavuzCeyda Dincer YazanZeliha HekimsoyKadriye AydinNaile GokkayaCanan ErsoyAysen AkalınÖmercan TopaloğluBerna İmge AydoğanEsra N A DilekciZiynet Alphan UcGüven Barış CansuLevent OzsariOzlem T IyidirMehtap E OlgunLezzan KeskinMeral MertBulent CanKagan GungorTayfun GalipZeynep CantürkGulsah ElbukenZafer PekkolayNilufer O KutbayGöknur YorulmazAhmet T KalkanYasemin A UnsalAdnan YayBaris KaragunEvin BozkurPublished in: Clinical endocrinology (2022)
In 29.2% of the DTC patients, serum TSH levels were at target levels. Remaining of the study group have TSH levels under or over treatment range, exposing the patient to medication side effects. Majorty of the study group 82.8% have good or moderate adherence to LT4 therapy. Reaching TSH targets requires simplified and applicable guidelines and following the guideline recommendations.